Target intelligence / Profile preview

Transmembrane channel-like protein 3 (TMC3)

Target
TMC3
Molecular classification
Ion channel, Transmembrane protein
01

Overview

Transmembrane channel-like protein 3 (TMC3) is a member of the TMC protein family, structurally characterized by multiple transmembrane domains and conservation across diverse animal species[1][2][3]. TMC3 is predicted to function as a mechanosensitive monoatomic ion channel, involved in monoatomic ion transmembrane transport, and may modulate membrane excitability[3]. Although TMC1 and TMC2 have established roles in mechanotransduction (notably in hearing), TMC3's physiological functions in mammals are less defined but have been experimentally shown to confer mechanosensory responses when ectopically expressed in model organisms such as Caenorhabditis elegans, suggesting potential involvement in sensory transduction[2]. Some evidence indicates TMC3 may be expressed in subsets of sensory neurons in mice and could play a role in mechanosensation or thermosensation, but direct evidence of its precise function and relevance as a therapeutic target remains lacking[2]. No clinically validated drugs or biomarkers are currently associated with TMC3; its designation as a direct therapeutic target is not supported by current knowledge[1][3].

Other names
TMC3transmembrane channel-like 3transmembrane channel-like protein 3
02

Biological functions

MechanosensationIon transmembrane transportModulation of membrane excitabilitySensory transduction (putative)
03

Disease associations

Epidermodysplasia verruciformis (as a genetic association)Other (no prominent direct involvement in major human diseases established)
04

Safety considerations

Limited functional characterization; unknown off-target or systemic effects if targeted

Beyond the preview

Go deeper on Transmembrane channel-like protein 3 (TMC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane channel-like protein 3 (TMC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call